BridgeBio Oncology Therapeutics, Inc. (BBOT) — Shareholders' Equity
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $411.10M | +330.1% |
| 2024 | -$178.64M | -54.5% |
| 2023 | -$115.64M | -528496.2% |
| 2022 | -$21.9K | — |
| Fiscal Year | Shareholders' Equity | Change YoY |
|---|---|---|
| 2025 | $411.10M | +330.1% |
| 2024 | -$178.64M | -54.5% |
| 2023 | -$115.64M | -528496.2% |
| 2022 | -$21.9K | — |